about
Anti-diabetic effects of Caulerpa lentillifera: stimulation of insulin secretion in pancreatic β-cells and enhancement of glucose uptake in adipocytes.Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals.Aberrant Pregnancy Adaptations in the Peripheral Immune Response in Type 1 Diabetes: A Rat Model.Vaccination against type 1 diabetes.Lespedeza davurica (Lax.) Schindl. extract protects against cytokine-induced β-cell damage and streptozotocin-induced diabetesAssociation of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population.Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD miceTSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicityThymus and aging: morphological, radiological, and functional overview.DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes.Combination Immunotherapy for Type 1 Diabetes.Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.Vitamin D status and the predictors of circulating T helper 1-type immunoglobulin levels in Iranian subjects with type 1 diabetes and their siblings: a case-control study.Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation in the absence of GAD and IA-2 autoantibodies.
P2860
Q33657590-ABF61B76-7D5C-4076-9566-047787F1ED00Q34586781-7A1BE096-F861-492D-8A64-7DEC3E0DD5F6Q34785213-28EA3BDD-0F02-4E18-A841-BBB740B1CFF8Q35004343-3AAE8165-FD39-4E70-9731-6759794FA377Q35156175-FD885FA9-8B78-4617-93CF-6568FC28E51CQ35867243-2FCEA7F1-07D5-4F5F-8008-913F938C7F45Q36824703-0F0A2B6A-4142-4793-ABFA-87AFCF3ECCEDQ36867533-03AB42CA-9F23-4D2A-986E-7B58E2C60E0FQ37471102-7F337AF6-FB65-40D5-AEAF-BC2095D4426FQ37900639-3D0E1C77-681F-4763-8EEC-8F0FFBE30EF8Q38680333-616ACE7F-863C-4B73-9B59-5EC04C7AD244Q38908327-6E5EF7CD-9F0E-4A4A-B5D5-DD118EB52F01Q42030632-723024F2-E2C5-4C0B-A6C2-ED283C909EF9Q44813003-AAB0E8FF-65EC-4DAA-9F9D-140050EA2767Q51364246-56FF9623-1519-45CA-9BE7-DA2018624D4F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmunity and the pathogenesis of type 1 diabetes.
@en
Autoimmunity and the pathogenesis of type 1 diabetes.
@nl
type
label
Autoimmunity and the pathogenesis of type 1 diabetes.
@en
Autoimmunity and the pathogenesis of type 1 diabetes.
@nl
prefLabel
Autoimmunity and the pathogenesis of type 1 diabetes.
@en
Autoimmunity and the pathogenesis of type 1 diabetes.
@nl
P2093
P2860
P1476
Autoimmunity and the pathogenesis of type 1 diabetes.
@en
P2093
Andrew W Lyon
Morley D Hollenberg
Thomas R Csorba
P2860
P356
10.3109/10408361003787171
P577
2010-03-01T00:00:00Z